[Hiroshi Ohno] Establishment of the platform for the control and prevention of allergy by omics-based understanding of its pathogenesis


Research Director

Hiroshi Ohno

Hiroshi Ohno

Center for Integrative Medical Sciences, RIKEN
Group Director


Outline

Allergic diseases is steadily increasing in recent years. It is believed that allergy will develop by the combination of genetic factors and environmental factors; for the latter, attention has been focused on the importance of metabolites and biologically active substances produced by intestinal microbiota, as well as in breast milk . In this study, we aim to identify potential biomarkers for allergy-developing/aggravating factors, with particular emphasis on the lipids. by high-precision and cyclopedic omics analysis of metabolites and physiological active substances in breast milk and intestinal microbiota.

Quick Access

Quick Access

 News

arrow On-going

arrow Completed

Program

  • CREST
  • PRESTO
  • ACT-I
  • ERATO
  • ACT-C
  • ACCEL
  • ALCA
  • RISTEX
Finish programs
  • Pamphlet
  • ProjectDB
  • GlobalActivity
  • Diversity-EN
  • OS_Policy-EN
  • Question-E